Publisher: VSP
ISSN: 1568-5608
Source: Inflammopharmacology, Vol.9, Iss.4, 2001-08, pp. : 401-401
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Amphotericin B Formulations – The Possibility of Generic Competition
Pharmaceutical Nanotechnology, Vol. 1, Iss. 4, 2013-11 ,pp. :
NR2B subtype-selective NMDA receptor antagonists: 2001 – 2004
Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. :